Cite

HARVARD Citation

    Kobayashi, N. et al. (2017). Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure. Medicine. 96 (19), p. . [Online]. 
  
Back to record